DE69807200D1 - Inklusionskomplexe in waessriger loesung - Google Patents

Inklusionskomplexe in waessriger loesung

Info

Publication number
DE69807200D1
DE69807200D1 DE69807200T DE69807200T DE69807200D1 DE 69807200 D1 DE69807200 D1 DE 69807200D1 DE 69807200 T DE69807200 T DE 69807200T DE 69807200 T DE69807200 T DE 69807200T DE 69807200 D1 DE69807200 D1 DE 69807200D1
Authority
DE
Germany
Prior art keywords
aqueous solution
inclusive complexes
complexes
inclusive
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69807200T
Other languages
English (en)
Inventor
Rudkjaer Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE69807200D1 publication Critical patent/DE69807200D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69807200T 1997-02-27 1998-02-25 Inklusionskomplexe in waessriger loesung Expired - Lifetime DE69807200D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK21697 1997-02-27
PCT/DK1998/000073 WO1998037884A1 (en) 1997-02-27 1998-02-25 Inclusion complexes in aqueous solution

Publications (1)

Publication Number Publication Date
DE69807200D1 true DE69807200D1 (de) 2002-09-19

Family

ID=8091048

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69807200T Expired - Lifetime DE69807200D1 (de) 1997-02-27 1998-02-25 Inklusionskomplexe in waessriger loesung

Country Status (7)

Country Link
EP (1) EP0973519B1 (de)
JP (1) JP2001515473A (de)
AT (1) ATE222103T1 (de)
AU (1) AU6290398A (de)
DE (1) DE69807200D1 (de)
WO (1) WO1998037884A1 (de)
ZA (1) ZA981558B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187000B1 (en) 1998-08-20 2001-02-13 Endius Incorporated Cannula for receiving surgical instruments
ATE248165T1 (de) * 1999-07-01 2003-09-15 Italfarmaco Spa Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
US7056321B2 (en) 2000-08-01 2006-06-06 Endius, Incorporated Method of securing vertebrae
PE20020300A1 (es) 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
AU6290398A (en) 1998-09-18
WO1998037884A1 (en) 1998-09-03
ZA981558B (en) 1998-08-27
EP0973519B1 (de) 2002-08-14
ATE222103T1 (de) 2002-08-15
JP2001515473A (ja) 2001-09-18
EP0973519A1 (de) 2000-01-26

Similar Documents

Publication Publication Date Title
DK1200418T3 (da) Nematodicide trifluorbutener
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
ATE320457T1 (de) Polyurethanlösungen mit alkoxysilanstruktureinheiten
ATE231872T1 (de) Thiazolopyrimidinderivate
IT1285770B1 (it) Composti corticoidei
DK261490D0 (da) New pharmaceutical compound
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
ATE265455T1 (de) Tetrahydropyridoverbindungen
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
PT1244643E (pt) Inibidores da triptase
NO20005548D0 (no) Mykobakterieinhibitorer
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
PT1244614E (pt) Inibidores de triptase
DK1144423T3 (da) Bis-terpyridin-platin(II)-komplekser
EA200000163A1 (ru) Противоопухолевое средство
DE60003074D1 (de) Fusidinsäure-derivate
TR200003084T2 (tr) Paroxetine askorbat
ES2183543T3 (es) Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
SU1455632A1 (ru) О,о-диэтил-n-(1-пропилтио-2-гидрокси-2-метилпропилиден)-амидотиофосфат, обладающий бактерицидной активностью

Legal Events

Date Code Title Description
8332 No legal effect for de